tiprankstipranks
Corvus publishes data on potential of soquelitinib to modulate tumor activity
PremiumThe FlyCorvus publishes data on potential of soquelitinib to modulate tumor activity
18d ago
Corvus Pharmaceuticals announces preclinical dataon soquelitinib
Premium
The Fly
Corvus Pharmaceuticals announces preclinical dataon soquelitinib
1M ago
Corvus Pharmaceuticals price target raised to $13 from $8 at Jefferies
Premium
The Fly
Corvus Pharmaceuticals price target raised to $13 from $8 at Jefferies
1M ago
Corvus Pharmaceuticals options imply 17.7% move in share price post-earnings
PremiumThe FlyCorvus Pharmaceuticals options imply 17.7% move in share price post-earnings
1M ago
Corvus Pharmaceuticals options imply 12.0% move in share price post-earnings
Premium
The Fly
Corvus Pharmaceuticals options imply 12.0% move in share price post-earnings
2M ago
Is CRVS a Buy, Before Earnings?
Premium
Pre-Earnings
Is CRVS a Buy, Before Earnings?
2M ago
Corvus Pharmaceuticals initiates registrational Phase 3 trial of soquelitinib
PremiumThe FlyCorvus Pharmaceuticals initiates registrational Phase 3 trial of soquelitinib
3M ago
Corvus Pharmaceuticals files $200M mixed securities shelf
Premium
The Fly
Corvus Pharmaceuticals files $200M mixed securities shelf
5M ago
Corvus Pharmaceuticals sees  cash to fund operations into Q4
Premium
The Fly
Corvus Pharmaceuticals sees cash to fund operations into Q4
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100